Your browser doesn't support javascript.
loading
Real-world efficacy and potential mechanism of resistance of icotinib in Asian advanced non-small cell lung cancer with EGFR uncommon mutations: A multi-center study.
Lei, Lei; Wang, Wen-Xian; Zhu, You-Cai; Li, Jin-Luan; Fang, Yong; Wang, Hong; Zhuang, Wu; Zhang, Yin-Bin; Wang, Li-Ping; Fang, Mei-Yu; Xu, Chun-Wei; Wang, Xiao-Jia; Lv, Tang-Feng; Song, Yong.
Afiliação
  • Lei L; Department of Medical Oncology, Cancer Hospital of University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, People's Republic of China.
  • Wang WX; Department of Medical Oncology, Cancer Hospital of University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, People's Republic of China.
  • Zhu YC; Department of Thoracic Disease Center, Zhejiang Rongjun Hospital, Jiaxing, Zhejiang, People's Republic of China.
  • Li JL; Department of Radiotherapy, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, People's Republic of China.
  • Fang Y; Department of Oncology, Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, People's Republic of China.
  • Wang H; Department of Lung Cancer, The Fifth Medical Center, General of PLA, Beijing, People's Republic of China.
  • Zhuang W; Department of Medical Oncology, Fujian Provincial Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, Fujian, People's Republic of China.
  • Zhang YB; Department of Oncology, The Second Affiliated Hospital of Medical College, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.
  • Wang LP; Department of Oncology, Baotou Cancer Hospital, Baotou, Inner Mongolia, People's Republic of China.
  • Fang MY; Department of Medical Oncology, Cancer Hospital of University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, People's Republic of China.
  • Xu CW; Department of Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, Fujian, People's Republic of China.
  • Wang XJ; Department of Medical Oncology, Cancer Hospital of University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, People's Republic of China.
  • Lv TF; Department of Respiratory Medicine, Jinling Hospital, Nanjing, Jiangsu, People's Republic of China.
  • Song Y; Department of Respiratory Medicine, Jinling Hospital, Nanjing, Jiangsu, People's Republic of China.
Cancer Med ; 9(1): 12-18, 2020 01.
Article em En | MEDLINE | ID: mdl-31692291

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 3_diarrhea / 4_diarrhoeal_infections / 6_other_respiratory_diseases / 6_trachea_bronchus_lung_cancer Assunto principal: Quinazolinas / Carcinoma Pulmonar de Células não Pequenas / Resistencia a Medicamentos Antineoplásicos / Éteres de Coroa / Inibidores de Proteínas Quinases / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Cancer Med Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 3_diarrhea / 4_diarrhoeal_infections / 6_other_respiratory_diseases / 6_trachea_bronchus_lung_cancer Assunto principal: Quinazolinas / Carcinoma Pulmonar de Células não Pequenas / Resistencia a Medicamentos Antineoplásicos / Éteres de Coroa / Inibidores de Proteínas Quinases / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Cancer Med Ano de publicação: 2020 Tipo de documento: Article
...